OSH Stock Overview
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States.
Oak Street Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$20.14|
|52 Week High||US$66.31|
|52 Week Low||US$19.72|
|1 Month Change||-40.71%|
|3 Month Change||-54.65%|
|1 Year Change||-62.51%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-49.65%|
Recent News & Updates
Oak Street Health Grows Revenue But Struggles With Higher Medical Costs
Oak Street Health went public in August 2020, raising $328 million in an IPO. The firm provides senior populations with primary care services in the Midwest U.S. OSH has been growing revenue but dealing with much higher disease burden costs, which management says it can better control in 2022. I'm Neutral on the stock until we see evidence of management's contention of better results in 2022.
|OSH||US Healthcare||US Market|
Return vs Industry: OSH underperformed the US Healthcare industry which returned 13.9% over the past year.
Return vs Market: OSH underperformed the US Market which returned 10.2% over the past year.
|OSH Average Weekly Movement||11.3%|
|Healthcare Industry Average Movement||8.0%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.8%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: OSH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: OSH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
Oak Street Health Fundamentals Summary
|OSH fundamental statistics|
Is OSH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OSH income statement (TTM)|
|Cost of Revenue||US$1.22b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-1.49|
|Net Profit Margin||-27.81%|
How did OSH perform over the long term?See historical performance and comparison
Is Oak Street Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OSH ($20.14) is trading below our estimate of fair value ($104.3)
Significantly Below Fair Value: OSH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OSH is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: OSH is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OSH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OSH is overvalued based on its PB Ratio (32.1x) compared to the US Healthcare industry average (2.6x).
How is Oak Street Health forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OSH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OSH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OSH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OSH's revenue (28.4% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: OSH's revenue (28.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OSH's Return on Equity is forecast to be high in 3 years time
How has Oak Street Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OSH is currently unprofitable.
Growing Profit Margin: OSH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: OSH is unprofitable, and losses have increased over the past 5 years at a rate of 33.5% per year.
Accelerating Growth: Unable to compare OSH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OSH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).
Return on Equity
High ROE: OSH has a negative Return on Equity (-238.46%), as it is currently unprofitable.
How is Oak Street Health's financial position?
Financial Position Analysis
Short Term Liabilities: OSH's short term assets ($1.5B) exceed its short term liabilities ($544.9M).
Long Term Liabilities: OSH's short term assets ($1.5B) exceed its long term liabilities ($1.1B).
Debt to Equity History and Analysis
Debt Level: OSH has more cash than its total debt.
Reducing Debt: Insufficient data to determine if OSH's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OSH has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if OSH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Oak Street Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OSH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OSH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OSH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OSH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OSH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mike Pykosz (38 yo)
Mr. Michael T. Pykosz, also known as Mike, Co-Founded Oak Street Health, Inc. in 2012 and has been its Chairman & CEO since 2012. He serves as President of Oak Street Health, Inc. He co-founded Oak Street...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD73.55M) is above average for companies of similar size in the US market ($USD6.41M).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
Experienced Management: OSH's management team is considered experienced (4 years average tenure).
Experienced Board: OSH's board of directors are considered experienced (6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Oak Street Health, Inc.'s employee growth, exchange listings and data sources
- Name: Oak Street Health, Inc.
- Ticker: OSH
- Exchange: NYSE
- Founded: 2012
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$4.852b
- Shares outstanding: 240.93m
- Website: https://www.oakstreethealth.com
Number of Employees
- Oak Street Health, Inc.
- 30 West Monroe Street
- Suite 1200
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/19 00:09|
|End of Day Share Price||2022/01/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.